Key result
The ETA receptor antagonist BQ123 increased afferent renal nerve activity responses to elevated renal pelvic pressure in CHF rats compared to vehicle (21% vs 12%; p<0.05).
Why the study?
Does ETA receptor antagonism with BQ123 improve the responsiveness of renal mechanosensory nerves in CHF rats?
Does ETA receptor antagonism with BQ123 improve the responsiveness of renal mechanosensory nerves in CHF rats?
Absolute Event Rate: 21% vs 12%
p-value: p=<0.05
Activation of ETA receptors contributes to the impaired responsiveness of renal mechanosensory nerves in congestive heart failure, suggesting a mechanism for increased renal sympathetic nerve activity and sodium retention.
ETA blockade may restore renal afferent responses in experimental CHF; leaves open clinical relevance for sympathetic modulation in patients.
Increasing renal pelvic pressure results in PGE2-mediated release of substance P, leading to increases in afferent renal nerve activity (ARNA) and natriuresis, that is, a renorenal reflex response. The renorenal reflexes are impaired in congestive heart failure (CHF). Impairment of the renorenal reflexes may contribute to the increased renal sympathetic nerve activity and sodium retention in CHF. Endothelin (ET)-1 contributes to the pathological changes in cardiac and renal function in CHF. Therefore, we examined whether the ETA receptor antagonist BQ123 altered the responsiveness of renal mechanosensory nerves in CHF. The ARNA responses to increasing renal pelvic pressure were suppressed in CHF but not in sham-CHF rats. In CHF, increasing renal pelvic pressure by 7.5 mm Hg before and during renal pelvic perfusion with BQ123 increased ARNA 12% +/- 3% and 21% +/- 3% (p < 0.05 vs. vehicle). In isolated renal pelvises from CHF rats, PGE2 increased substance P release from 5 +/- 0 to 7 +/- 1 pg/min without BQ123 and from 4 +/- 1 to 9 +/- 1 pg/min with BQ123 in the bath (p < 0.01 vs. vehicle). BQ123 had no effect on the ARNA responses or substance P release in sham-CHF. In conclusion, activation of ETA receptors contributes to the impaired responsiveness of renal mechanosensory nerves in CHF rats by a mechanism(s) at the renal sensory nerve endings.
No takes yet. Share an insight, caveat, or question.
Kopp et al. (2010) studied Congestive heart failure. BQ123 (ETA receptor antagonist) vs. Vehicle was evaluated on Afferent renal nerve activity (ARNA) response to increasing renal pelvic pressure by 7.5 mm Hg (p=<0.05). The ETA receptor antagonist BQ123 increased afferent renal nerve activity responses to elevated renal pelvic pressure in CHF rats compared to vehicle (21% vs 12%; p<0.05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: